Accuracy of concurrent visual and cytology screening in detecting cervical cancer precursors in rural India

International Journal of Cancer

Volumn 131, Issue 6, 2012, Pages

  Deodhar, Kedar ^a   Sankaranarayanan, Rengaswamy ^b   Jayant, Kasturi ^c   Jeronimo, Jose ^d   Thorat, Ranjit ^c   Hingmire, Sanjay ^c   Muwonge, Richard ^b   Chiwate, Aruna ^c   Deshpande, Rutha ^c   Ajit, Dulhan ^a   Kelkar, Rohini ^a   Rekhi, Bharat ^a   Ruben, Irene ^a   Malvi, Sylla G ^c   Chinoy, Roshni ^a   Jambhekar, Nirmala ^a   Nene, Bhagwan M ^c  

^a TATA MEMORIAL HOSPITAL   (India)

^b INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

^c Nargis Dutt Memorial Cancer Hospital (NDMCH)   (India)

^d PATH   (United States)

Author keywords

cervical intraepithelial neoplasia; cytology; visual inspection with acetic acid; visual inspection with Lugol's iodine

Indexed keywords

ACETIC ACID; LUGOL; PROTEIN P16;

ADULT; ARTICLE; CANCER DIAGNOSIS; CANCER GRADING; CANCER SCREENING; CANCER THERAPY; CROSS-SECTIONAL STUDY; CRYOTHERAPY; DIAGNOSTIC ACCURACY; FEMALE; FOLLOW UP; HUMAN; INDIA; INFECTION RISK; LOOP ELECTROSURGICAL EXCISION PROCEDURE; MAJOR CLINICAL STUDY; PHYSICAL EXAMINATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; REPRODUCIBILITY; RURAL AREA; SCREENING TEST; SENSITIVITY AND SPECIFICITY; SURGICAL TECHNIQUE; UTERINE CERVIX CARCINOMA IN SITU; UTERINE CERVIX CYTOLOGY; VALIDITY; VISUAL INSPECTION WITH ACETIC ACID; VISUAL INSPECTION WITH LUGOL IODINE; VISUAL SCREENING TEST; WART VIRUS;

ACETIC ACID; ADULT; CERVICAL INTRAEPITHELIAL NEOPLASIA; CROSS-SECTIONAL STUDIES; CYTODIAGNOSIS; FEMALE; HUMANS; INDIA; MIDDLE AGED; NEOPLASM PROTEINS; PRECANCEROUS CONDITIONS; REFERENCE STANDARDS; SENSITIVITY AND SPECIFICITY; UTERINE CERVICAL NEOPLASMS;

EID: 84864121821     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.27633     Document Type: Article

References (28)

1. Sankaranarayanan R, Budukh AM, Rajkumar R,. Effective screening programmes for cervical cancer in low- and middle-income developing countries. Bull World Health Organ 2001; 79: 954-62.
2. IARC. IARC handbooks on cancer prevention, Vol. 10. Cervix cancer screening. Lyon: International Agency for Research on Cancer, 2005.
3. Ferlay J, Shin HR, Bray F, et al. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 2010; 127: 2893-917.
4. Denny L, Kuhn L, Hu CC, et al. Human papillomavirus-based cervical cancer prevention: long-term results of a randomized screening trial. J Natl Cancer Inst 2010; 102: 1557-67.
5. Qiao YL, Sellors JW, Eder PS, et al. A new HPV-DNA test for cervical-cancer screening in developing regions: a cross-sectional study of clinical accuracy in rural China. Lancet Oncol 2008; 9: 929-36.
6. Reuschenbach M, Seiz M, von Knebel DC, et al. Evaluation of cervical cone biopsies for coexpression of p16INK4a and Ki-67 in epithelial cells. Int J Cancer 2012; 130: 388-94.
7. Sankaranarayanan R, Nene BM, Shastri SS, et al. HPV screening for cervical cancer in rural India. N Engl J Med 2009; 360: 1385-94.
8. Sankaranarayanan R, Wesley RS,. A practical manual on visual screening for cervical neoplasia. IARC Technical Publication No. 41. Lyon: International Agency for Research on Cancer, 2003.
9. Sellors J, Sankaranarayanan R,. Colposcopy and treatment of cervical intraepithelial neoplasia: a beginners' manual. Lyon: International Agency for Research on Cancer, 2003.
10. Pretorius RG, Zhang WH, Belinson JL, et al. Colposcopically directed biopsy, random cervical biopsy, and endocervical curettage in the diagnosis of cervical intraepithelial neoplasia II or worse. Am J Obstet Gynecol 2004; 191: 430-4.
11. Solomon D, Davey D, Kurman R, et al. The 2001 Bethesda System: terminology for reporting results of cervical cytology. JAMA 2002; 287: 2114-9.
12. Tavassoéli FA, Devilee P,. Pathology and genetics tumours of the breast and female genital organs. WHO classification of tumors, 3rd edn., vol. 4. Lyon: International Agency for Research on Cancer, 2003.
13. Tsoumpou I, Arbyn M, Kyrgiou M, et al. p16(INK4a) immunostaining in cytological and histological specimens from the uterine cervix: a systematic review and meta-analysis. Cancer Treat Rev 2009; 35: 210-20.
14. Gheit T, Landi S, Gemignani F, et al. Development of a sensitive and specific assay combining multiplex PCR and DNA microarray primer extension to detect high-risk mucosal human papillomavirus types. J Clin Microbiol 2006; 44: 2025-31.
15. Saiki RK, Gelfand DH, Stoffel S, et al. Primer-directed enzymatic amplification of DNA with a thermostable DNA polymerase. Science 1988; 239: 487-91.
16. StataCorp LP,. Stata base reference manual: Release 9. College Station, TX: StataCorp LP, 2005.
17. Schiffman M, Wentzensen N, Wacholder S, et al. Human papillomavirus testing in the prevention of cervical cancer. J Natl Cancer Inst 2011; 103: 368-83.
18. Sankaranarayanan R, Gaffikin L, Jacob M, et al. A critical assessment of screening methods for cervical neoplasia. Int J Gynaecol Obstet 2005; 89 (Suppl 2): S4-S12.
19. Sankaranarayanan R, Thara S, Sharma A, et al. Accuracy of conventional cytology: results from a multicentre screening study in India. J Med Screen 2004; 11: 77-84.
20. Volgareva G, Zavalishina L, Andreeva Y, et al. Protein p16 as a marker of dysplastic and neoplastic alterations in cervical epithelial cells. BMC Cancer 2004; 4: 58.
21. Missaoui N, Hmissa S, Sankaranarayanan R, et al. [p16INK4A overexpression is a useful marker for uterine cervix lesions]. Ann Biol Clin (Paris) 2010; 68: 409-14.
22. Ishikawa M, Fujii T, Saito M, et al. Overexpression of p16 INK4a as an indicator for human papillomavirus oncogenic activity in cervical squamous neoplasia. Int J Gynecol Cancer 2006; 16: 347-53.
23. Ekalaksananan T, Pientong C, Kongyingyoes B, et al. Combined p16INK4a and human papillomavirus testing improves the prediction of cervical intraepithelial neoplasia (CIN II-III) in Thai patients with low-grade cytological abnormalities. Asian Pac J Cancer Prev 2011; 12: 1777-83.
24. Kuhn L, Wang C, Tsai WY, et al. Efficacy of human papillomavirus-based screen-and-treat for cervical cancer prevention among HIV-infected women. AIDS 2010; 24: 2553-61.
25. Luciani S, Munoz S, Gonzales M, et al. Effectiveness of cervical cancer screening using visual inspection with acetic acid in Peru. Int J Gynaecol Obstet 2011; 115: 53-6.
26. Sankaranarayanan R, Esmy PO, Rajkumar R, et al. Effect of visual screening on cervical cancer incidence and mortality in Tamil Nadu, India: a cluster-randomised trial. Lancet 2007; 370: 398-406.
27. Swaminathan R, Selvakumaran R, Esmy PO, et al. Cancer pattern and survival in a rural district in South India. Cancer Epidemiol 2009; 33: 325-31.
28. Sauvaget C, Fayette JM, Muwonge R, et al. Accuracy of visual inspection with acetic acid for cervical cancer screening. Int J Gynaecol Obstet 2011; 113: 14-24.